ANDA 202374, held by Epic Pharma LLC. Triamcinolone Acetonide.
As of Nov 15, 2026, ANDA 202374 (Triamcinolone Acetonide), held by Epic Pharma LLC, was first approved by FDA on May 8, 2013, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 8, 2013 | Original application | Approved | None posted |
| Triamcinolone Acetonide0.025% · lotion;topical | Triamcinolone Acetonide | Rx |
| Triamcinolone Acetonide0.1% · lotion;topical | Triamcinolone Acetonide | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
